Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Prev Post Binding Commitments Received for A$1.0 Million under Convertible Note Placement April 28, 2025 Next Post RHI: Acqn of royalty over Sandstone Gold Project tenements April 28, 2025 Related Posts Vale CEO: Real Assets Gaining Traction as Money Shifts Away from Tech March 3, 2026 Syntholene Energy Corp. Closes Oversubscribed $3.75 Million Non-Brokered Private Placement March 3, 2026 Valeura Energy Inc. Announces Thailand to Prioritise Domestic Energy Supply March 3, 2026
Syntholene Energy Corp. Closes Oversubscribed $3.75 Million Non-Brokered Private Placement March 3, 2026